Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Engstad
Pal-Kristian Engstad, Los Angeles, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20100283783 | Environment Mapping - A system and method for environment mapping determines a computer-generated object's reflective appearance, based upon position and orientation of a camera with respect to the object's location. An embodiment of the present invention is implemented as a real-time environment mapping for polygon rendering, however, the scope of the invention covers other rendering schemes. According to one embodiment of the present invention, a vector processing unit (VPU) uses a modified reflection formula—r=e−(e·(n+e | 11-11-2010 |
Pal-Kristian Engstad, Tokyo JP
| Patent application number | Description | Published |
|---|---|---|
| 20090002380 | Graphics Processing Apparatus, Graphics Library Module And Graphics Processing Method - There is provided a graphics processing system that includes a main processing unit and a graphics processing unit (GPU). The main processing unit puts rendering commands generated using a graphics library in the queue of a command buffer in a main memory. In this process, the library function offered by the graphics library is converted into the rendering commands, without any rendering attributes retained in the library. The GPU reads and executes the rendering commands stacked in the command buffer, and generates rendering data in a frame buffer. | 01-01-2009 |
Rolf Engstad, Tromso NO
| Patent application number | Description | Published |
|---|---|---|
| 20110104208 | Enzyme Treatment of Glucans - β-(1-6)-Glucanese treatment of glucan from yeast cells, pure or feed grade, especially yeast from the family | 05-05-2011 |
Rolf Einar Engstad, Tromson NO
| Patent application number | Description | Published |
|---|---|---|
| 20110008476 | Methods of Treating or Preventing Inflammatory Diseases of the Intestinal Tract - The present invention relates to a glucan derived from yeast having a beta-(1, 3)-backbone with one or more beta-(1, 3)-side chains linked thereto for use in the treatment or prevention of inflammatory bowel disease and related diseases of abnormal bowel function in an animal, in particular to such uses employing a soluble glucan, e.g. from | 01-13-2011 |
Rolf Einar Engstad, Tromoso NO
| Patent application number | Description | Published |
|---|---|---|
| 20090004201 | Therapy-Enhancing Glucan - A therapeutic composition for treatment of cancer in a mammal is disclosed. The composition comprises an effective amount of a yeast beta-glucan composition which is suitable for oral administration and for absorption through the gastrointestinal tract of the mammal. The above therapeutic composition may further comprise antitumor antibodies or cancer vaccine composition, wherein the antitumor activities of the antitumor antibodies or the cancer vaccine composition are enhanced by the yeast glucan. | 01-01-2009 |
| 20090053221 | IMMUNE RESPONSE ENHANCING GLUCAN - This invention discloses a composition for enhancing the protective immunity in a subject, comprising an effective amount of a β-glucan and a vaccine, wherein the β-glucan enhances the immune response of the vaccine against cancer or infectious agents. The infectious agents can be viruses, fungi, bacteria or parasites. In one embodiment, the β-glucan is derived from yeast and comprises side chains attached to a β-(1,3) backbone. In another embodiment, the vaccine comprises an antibody and whole tumor cells. The invention also provides a method of enhancing protective immunity using said composition. | 02-26-2009 |